Back to Search Start Over

Randomized phase II trial to evaluate the safety and efficacy of neoadjuvant cisplatin in combination with taxanes-anthracyclines vs taxanes-anthracyclines alone in locally advanced triple negative breast cancer

Randomized phase II trial to evaluate the safety and efficacy of neoadjuvant cisplatin in combination with taxanes-anthracyclines vs taxanes-anthracyclines alone in locally advanced triple negative breast cancer

Authors :
Hector Maldonado
Fernando Lara-Medina
Maria Cristina Aguilar Martinez
Juan Antonio Matus
Víctor Pérez-Sánchez
Robin Shaw-Dulin
Leticia Mendoza-Galindo
D. Flores-Díaz
Enrique Bargallo-Rocha
Claudia Arce-Salinas
Alberto Alvarado-Miranda
Source :
Journal of Clinical Oncology. 33:e12024-e12024
Publication Year :
2015
Publisher :
American Society of Clinical Oncology (ASCO), 2015.

Abstract

e12024 Background: Triple negative breast cancer in our center represents 21% of all breast cancer cases. In these group of patients, its been suggested that cisplatin could improve breast cancer o...

Details

ISSN :
15277755 and 0732183X
Volume :
33
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi...........1ec2d993d7143daeab8534ec6e96f075
Full Text :
https://doi.org/10.1200/jco.2015.33.15_suppl.e12024